Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
Award Notice Posted
- Solicitation number
- N02CM77007-98
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Awarded
- to Alchem Laboratories Corporation
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- HHSN261201700020C Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
The Developmental Therapeutics Program (DTP) at the National Cancer Institute (NCI) supports the NCI's Experimental Therapeutics (NExT) program to facilitate the transition of novel drug discoveries into clinical trials of new cancer therapeutic agents. One of essential parts of the program involves the manufacture and supply of bulk chemicals/drugs that are prepared under the current Good Manufacturing Practice (c-GMP). The bulk drugs will be used to support pre-clinical studies and to prepare clinical products that are necessary to support human clinical trials under the NCI sponsorship or investigator initiated INDs.
Files
| File | Type | Posted |
|---|---|---|
| N02CM77007-98_Amendment_Two.pdf | ||
| N02CM77007-98_Amendment_One.pdf | ||
| RFP_N02CM77007-98_Solicitation_Final_03_03_17.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity